{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:03:30Z","timestamp":1761512610564},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":2406,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1038\/jid.2008.364","type":"journal-article","created":{"date-parts":[[2008,11,27]],"date-time":"2008-11-27T12:45:37Z","timestamp":1227789937000},"page":"1203-1207","source":"Crossref","is-referenced-by-count":7,"title":["Transient Anti-CD40L Co-Stimulation Blockade Prevents Immune Responses against Human Bullous Pemphigoid Antigen 2: Implications for Gene Therapy"],"prefix":"10.1016","volume":"129","author":[{"given":"Christoph M.","family":"Lanschuetzer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edit B.","family":"Olasz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zelmira","family":"Lazarova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim B.","family":"Yancey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2008.364_bb0010","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/sj.jid.5700016","article-title":"Tolerance induction by the blockade of CD40\/CD154 interaction in pemphigus vulgaris mouse model","volume":"126","author":"Aoki-Ota","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2008.364_bb0015","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-2230.2003.01192.x","article-title":"Type XVII collagen gene mutations in junctional epidermolysis bullosa and prospects for gene therapy","volume":"28","author":"Bauer","year":"2003","journal-title":"Clin Exp Dermatol"},{"key":"10.1038\/jid.2008.364_bb0020","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/sj.jid.5700216","article-title":"Fibroblasts as target cells for DEB gene therapy","volume":"126","author":"Chen","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2008.364_bb0025","first-page":"87","article-title":"Generalized atrophic benign epidermolysis bullosa","volume":"13","author":"Darling","year":"1997","journal-title":"Adv Dermatol"},{"key":"10.1038\/jid.2008.364_bb0030","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1089\/104303400750035825","article-title":"Toward epidermal stem cell-mediated ex vivo gene therapy of junctional epidermolysis bullosa","volume":"11","author":"Dellambra","year":"2000","journal-title":"Hum Gene Ther"},{"key":"10.1038\/jid.2008.364_bb0035","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1126\/science.7689748","article-title":"Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40","volume":"261","author":"Durie","year":"1993","journal-title":"Science"},{"key":"10.1038\/jid.2008.364_bb0040","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.4049\/jimmunol.157.7.3159","article-title":"Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice. Response correlates with the absence of an anti-antibody response","volume":"157","author":"Early","year":"1996","journal-title":"J Immunol"},{"key":"10.1038\/jid.2008.364_bb0045","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1093\/intimm\/dxh162","article-title":"The contribution of Fc effector mechanisms in the efficacy of anti-CD154 immunotherapy depends on the nature of the immune challenge","volume":"16","author":"Ferrant","year":"2004","journal-title":"Int Immunol"},{"key":"10.1038\/jid.2008.364_bb0050","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1074\/jbc.R400034200","article-title":"Collagenous transmembrane proteins: recent insights into biology and pathology","volume":"280","author":"Franzke","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1038\/jid.2008.364_bb0055","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1073\/pnas.93.6.2499","article-title":"CD40\u2013CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis","volume":"93","author":"Gerritse","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2008.364_bb0060","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/archderm.1982.01650180009008","article-title":"Generalized atrophic benign epidermolysis bullosa","volume":"118","author":"Hintner","year":"1982","journal-title":"Arch Dermatol"},{"key":"10.1038\/jid.2008.364_bb0065","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.4049\/jimmunol.163.9.4805","article-title":"CD40 ligand blockade induces CD4+ T cell tolerance and linked suppression","volume":"163","author":"Honey","year":"1999","journal-title":"J Immunol"},{"key":"10.1038\/jid.2008.364_bb0070","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1097\/01.TP.0000093462.16309.73","article-title":"CD154 on the surface of CD4+CD25+ regulatory T cells contributes to skin transplant tolerance","volume":"76","author":"Jarvinen","year":"2003","journal-title":"Transplantation"},{"key":"10.1038\/jid.2008.364_bb0075","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/jid.1998.3","article-title":"Gene therapy for genetic skin disease","volume":"110","author":"Khavari","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2008.364_bb0080","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/nm1504","article-title":"Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells","volume":"12","author":"Mavilio","year":"2006","journal-title":"Nat Med"},{"key":"10.1038\/jid.2008.364_bb0085","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.4049\/jimmunol.154.3.1470","article-title":"Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis","volume":"154","author":"Mohan","year":"1995","journal-title":"J Immunol"},{"key":"10.1038\/jid.2008.364_bb0090","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1073\/pnas.89.14.6550","article-title":"A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells","volume":"89","author":"Noelle","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2008.364_bb0095","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1046\/j.1523-1747.2003.12090.x","article-title":"Suppression of the immune response against exogenous desmoglein 3 in desmoglein 3 knockout mice: an implication for gene therapy","volume":"120","author":"Ohyama","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2008.364_bb0100","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1038\/sj.jid.5700970","article-title":"Human bullous pemphigoid antigen 2 transgenic skin elicits specific IgG in wild-type mice","volume":"127","author":"Olasz","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2008.364_bb0105","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2337\/diabetes.52.2.321","article-title":"NOD congenic mice genetically protected from autoimmune diabetes remain resistant to transplantation tolerance induction","volume":"52","author":"Pearson","year":"2003","journal-title":"Diabetes"},{"key":"10.1038\/jid.2008.364_bb0110","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1126\/science.8094901","article-title":"\u201cInfectious\u201d transplantation tolerance","volume":"259","author":"Qin","year":"1993","journal-title":"Science"},{"key":"10.1038\/jid.2008.364_bb0115","doi-asserted-by":"crossref","first-page":"7739","DOI":"10.1073\/pnas.85.20.7739","article-title":"Evidence that the effector mechanism of skin allograft rejection is antigen-specific","volume":"85","author":"Rosenberg","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2008.364_bb0120","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.4049\/jimmunol.151.5.2497","article-title":"The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells","volume":"151","author":"Roy","year":"1993","journal-title":"J Immunol"},{"key":"10.1038\/jid.2008.364_bb0125","first-page":"37","article-title":"BP180 (type XVII collagen) and its role in cutaneous biology and disease","volume":"19","author":"Van den Bergh","year":"2003","journal-title":"Adv Dermatol"},{"key":"10.1038\/jid.2008.364_bb0130","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jlb.67.1.2","article-title":"CD40\u2013CD40 ligand","volume":"67","author":"van Kooten","year":"2000","journal-title":"J Leukoc Biol"},{"key":"10.1038\/jid.2008.364_bb0135","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/sj.mt.6300041","article-title":"Intravenously injected human fibroblasts home to skin wounds, deliver type VII collagen, and promote wound healing","volume":"15","author":"Woodley","year":"2007","journal-title":"Mol Ther"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15343128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15343128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T14:56:00Z","timestamp":1684680960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15343128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0022202X15343128"],"URL":"https:\/\/doi.org\/10.1038\/jid.2008.364","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}